dihydroergotamine has been researched along with Liver Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, B; Fogh, J; Jørgensen, T; Kjaergaard, J; Munck, O; Thorup, J; Wille-Jørgensen, P | 1 |
| Azria, M; Chalas, J; Chaput, JC; Humbert, M; Labayle, D; Lavène, D; Lindenbaum, A | 1 |
1 trial(s) available for dihydroergotamine and Liver Diseases
| Article | Year |
|---|---|
Heparin with and without dihydroergotamine in prevention of thromboembolic complications of major abdominal surgery. A randomized trial.
Topics: Abdomen; Adolescent; Adult; Aged; Biliary Tract Diseases; Clinical Trials as Topic; Dihydroergotamine; Drug Therapy, Combination; Female; Heparin; Humans; Intestinal Diseases; Liver Diseases; Male; Middle Aged; Pancreatic Diseases; Postoperative Complications; Random Allocation; Stomach Diseases; Thromboembolism; Time Factors | 1983 |
1 other study(ies) available for dihydroergotamine and Liver Diseases
| Article | Year |
|---|---|
[Pharmacokinetics of dihydroergotamine in patients with chronic liver disease (author's transl)].
Topics: Adult; Aged; Chronic Disease; Dihydroergotamine; Humans; Kinetics; Liver Cirrhosis, Alcoholic; Liver Diseases; Middle Aged | 1982 |